Lung Cancer Targets and Therapy

译名:肺癌:靶点与治疗

Lung Cancer-Targets and Therapy

ESCIJCR Q2

3-5

2026

影响因子区间

平台估算

投稿周期

18%

2025

中国作者发文占比

40000000 IRR;600 USD

费用说明

收费

期刊简介:Lung Cancer: Targets and Therapy is an international, peer-reviewed, open access journal focusing on lung cancer research, identification of therapeutic targets and the best use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient. The journal’s audience includes clinicians, researchers, and medical oncologists involved in the prevention, diagnosis, and treatment of lung cancer. The journal is characterized by rigorous peer review, high impact reviews, and evidence-based research aimed at improving patient outcomes. Specific topics covered in the journal include: • Epidemiology, detection and screening • Cellular research and biomarkers • Identification of biotargets and agents with novel mechanisms of action • Optimal clinical use of existing anticancer agents, including combination therapies Lung Cancer: Targets and Therapy will no longer consider meta-analyses for publication. The journal welcomes submitted papers covering original research, basic science, clinical and epidemiological studies, reviews and evaluations, guidelines, expert opinion and commentary, case reports and extended reports.

【译文】《肺癌:目标与治疗》是一本经过同行评审的国际开放获取期刊,专注于肺癌研究、治疗目标的确定以及预防性和综合治疗干预措施的最佳利用,以改善癌症患者的预后、提高生存率和生活质量。该杂志的读者包括参与肺癌预防、诊断和治疗的临床医生、研究人员和肿瘤内科医生。该杂志的特点是严格的同行评审、高影响力的评审和旨在改善患者治疗效果的循证研究。该杂志涵盖的具体主题包括: • 流行病学、检测和筛查 • 细胞研究和生物标志物 • 识别具有新颖作用机制的生物靶点和药物 • 现有抗癌药物的最佳临床使用,包括联合疗法 肺癌:靶点和治疗将不再考虑发表荟萃分析。该杂志欢迎提交涵盖原始研究、基础科学、临床和流行病学研究、评论和评估、指南、专家意见和评论、病例报告和扩展报告的论文。

出版社
Dove Medical Press
语言
English
学科
医学 / 环境科学与生态学
ISSN
1179-2728
eISSN
1179-2728
出版频率
年刊
创刊年份
1981
投稿网址
https://www.dovepress.com/lung-cancer-targets--therapy-journal
最近更新
2026-04-02 18:16:40
Lung Cancer Targets and Therapy

指标当前值近三年趋势
JCR分区Q2
暂无
影响因子区间3-5
暂无